| Literature DB >> 27445633 |
Boaz Gedaliahu Samolsky Dekel1, Alberto Gori2, Alessio Vasarri2, Maria Cristina Sorella2, Gianfranco Di Nino1, Rita Maria Melotti1.
Abstract
Biased pain evaluation due to automated heuristics driven by symptom uncertainty may undermine pain treatment; medical evidence moderators are thought to play a role in such circumstances. We explored, in this cross-sectional survey, the effect of such moderators (e.g., nurse awareness of patients' pain experience and treatment) on the agreement between n = 862 inpatients' self-reported pain and n = 115 nurses' pain ratings using a numerical rating scale. We assessed the mean of absolute difference, agreement (κ-statistics), and correlation (Spearman rank) of inpatients and nurses' pain ratings and analyzed congruence categories' (CCs: underestimation, congruence, and overestimation) proportions and dependence upon pain categories for each medical evidence moderator (χ (2) analysis). Pain ratings agreement and correlation were limited; the CCs proportions were further modulated by the studied moderators. Medical evidence promoted in nurses overestimation of low and underestimation of high inpatients' self-reported pain. Knowledge of the negative influence of automated heuristics driven by symptoms uncertainty and medical-evidence moderators on pain evaluation may render pain assessment more accurate.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27445633 PMCID: PMC4904614 DOI: 10.1155/2016/9267536
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Summary of NEP-PSRP mean of NRS absolute differences, pain categories agreement/disagreement, and correlation.
| Moderatorsf | NRS | Pain categories | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Absolute differences | Agreement/disagreement (%) |
| Spearman correlation coefficient | ||||||
| [mean (95% CI)] | Underestimation | Agreement | Overestimation |
| Agreement based on |
| Correlation based on | ||
| Pain experience in the past 24 h | |||||||||
| No | 401 | 1.3 (1.1–1.5) | 21.2 | 67.3 | 11.5 | 0.08b | Poor | 0.55a | Moderate |
| Yes | 461 | 2.6 (2.4–2.8) | 21.0 | 34.7 | 44.3 | 0.14a | Mild | 0.40a | Moderate |
| Cause of pain | |||||||||
| Surgery | 173 | 2.9 (2.5–3.2) | 20.2 | 30.1 | 49.7 | 0.08c | Poor | 0.27b | Mild |
| Trauma | 24 | 2.8 (1.8–3.8) | 25.0 | 41.7 | 33.3 | 0.19d | — | 0.25d | — |
| Diagnostic procedures | 36 | 1.8 (0.8–2.7) | 13.9 | 50.0 | 36.1 | 0.13d | — | 0.47b | Moderate |
| Cancer | 39 | 3.3 (2.4–4.1) | 28.2 | 25.6 | 46.2 | 0.03d | — | 0.12d | — |
| Other | 167 | 2.4 (2.1–2.7) | 41.9 | 37.7 | 20.4 | 0.19a | Mild | 0.52a | Moderate |
| Unknown | 22 | 2.5 (1.6–3.5) | 40.9 | 31.8 | 27.3 | 0.09d | — | 0.41d | — |
| Analgesics in the past 24 h | |||||||||
| No | 676 | 1.8 (1.6–2.0) | 20.3 | 55.0 | 24.7 | 0.18a | Mild | 0.45a | Moderate |
| Yes | 179 | 2.9 (2.5–3.2) | 24.0 | 30.2 | 45.8 | 0.10b | Mild | 0.39a | Moderate |
| Analgesic administration regimen | |||||||||
|
| 64 | 2.5 (1.9–3.1) | 39.1 | 39.1 | 21.9 | 0.19b | Mild | 0.42a | Moderate |
|
| 95 | 3.1 (2.7–3.6) | 27.3 | 23.2 | 49.5 | 0.02d | — | 0.33b | Mild |
|
| 14 | 2.4 (1.1–3.7) | 14.3 | 35.7 | 50.0 | 0.11d | — | 0.57c | Moderate |
| NSAIDs | |||||||||
| Yes | 103 | 2.7 (2.3–3.2) | 23.3 | 30.1 | 46.6 | 0.11b | Mild | 0.47a | Moderate |
| NSAIDs administration regimen | |||||||||
|
| 25 | 2.2 (1.4–3.0) | 20.0 | 40.0 | 40.0 | 0.23c | Mild | 0.68a | Moderate |
|
| 68 | 3.0 (2.4–3.6) | 23.5 | 25.0 | 51.5 | 0.06d | — | 0.37b | Mild |
|
| 8 | 2.0 (0.0–4.0) | 25.0 | 37.5 | 37.5 | 0.13d | — | 0.44d | — |
| Opioids | |||||||||
| Yes | 63 | 3.4 (2.7–4.0) | 23.8 | 27.0 | 49.2 | 0.04d | — | 0.17d | — |
| Opioids administration regimen | |||||||||
|
| 30 | 3.2 (2.2–4.2) | 20.0 | 33.3 | 46.7 | 0.10d | — | 0.06d | — |
|
| 24 | 3.5 (2.6–4.5) | 37.5 | 16.7 | 45.8 | −0.10d | — | 0.20d | — |
|
| 5 | 2.8 (0.1–5.5) | 60.0 | 40.0 | 0.0 | 0.17d | — | 0.90d | — |
| NSAIDs + opioids | |||||||||
| Yes | 13 | 1.9 (0.8–3.1) | 30.8 | 46.2 | 23.1 | 0.28c | Mild | 0.75b | Strong |
| NSAIDs + opioids administration regimen | |||||||||
|
| 3 | 0.7 (0.0–2.1) | 33.3 | 66.8 | 11.1 | 0.50d | Moderate | 0.88d | — |
|
| 2 | 2.5 ( )e | 0.0 | 50.0 | 50.0 | 0.00e | — | 0.50d | — |
|
| 8 | 2.6 (0.7–3.8) | 37.5 | 37.5 | 25.0 | 0.17d | — | 0.79c | Strong |
For each congruence-moderator subset the table reports (1) the absolute NEP-PSRP NRS score differences as the mean and (95% confidence intervals, lower and upper levels); (2) proportions of PSRP-NEP pain categories agreement and disagreement (under- and overestimation); and (3) the results of the κ-statistic and the Spearman correlation coefficient analyses with both absolute numerical and category values.
CI: confidence intervals; NSAIDs: nonsteroidal anti-inflammatory drugs; ATC: around the clock; and PRN: on demand.
a P < 0.001, b P < 0.01, c P < 0.05, dstatistically insignificant, einsufficient cases for analysis, and fassessor's assertion.
Distribution and proportions of NEP and PSRP pain categories in the sample.
| Moderatorsa |
| Pain categories, | |||||||
|---|---|---|---|---|---|---|---|---|---|
| No-pain | Mild | Moderate | Severe | ||||||
| PSRP | NEP | PSRP | NEP | PSRP | NEP | PSRP | NEP | ||
| Pain experience in the past 24 h | |||||||||
| No | 401 | 301 (75.1) | 336 (83.8) | 39 (9.7) | 43 (10.7) | 39 (9.7) | 16 (4.0) | 22 (5.5) | 6 (1.5) |
| Yes | 461 | 234 (40.8) | 98 (21.3) | 65 (14.1) | 156 (33.8) | 90 (19.5) | 138 (29.9) | 72 (15.6) | 69 (15.0) |
| Cause of pain | |||||||||
| Surgery | 173 | 88 (50.9) | 34 (19.7) | 35 (20.2) | 64 (37.0) | 31 (17.9) | 50 (28.9) | 19 (11.0) | 25 (14.4) |
| Trauma | 24 | 6 (25.0) | 3 (12.5) | 2 (8.3) | 5 (20.8) | 9 (37.5) | 10 (41.7) | 7 (29.2) | 6 (25.0) |
| Diagnostic procedures | 36 | 27 (75.0) | 19 (52.8) | 1 (2.8) | 11 (30.6) | 4 (11.1) | 4 (11.1) | 4 (11.1) | 2 (5.6) |
| Cancer | 39 | 16 (41.0) | 3 (7.7) | 5 (12.8) | 11 (28.2) | 11 (28.2) | 18 (46.2) | 7 (17.9) | 7 (17.9) |
| Other | 167 | 84 (50.3) | 33 (19.8) | 21 (12.6) | 57 (34.1) | 30 (18.0) | 50 (29.9) | 32 (19.2) | 27 (16.2) |
| Unknown | 22 | 13 (59.1) | 6 (27.3) | 1 (4.5) | 8 (36.4) | 5 (22.7) | 6 (27.3) | 3 (13.6) | 2 (9.1) |
| Analgesics in the past 24 h | |||||||||
| No | 676 | 458 (67.8) | 404 (59.8) | 75 (11.1) | 150 (22.2) | 89 (13.2) | 91 (13.5) | 54 (8.0) | 31 (4.6) |
| Yes | 179 | 73 (40.8) | 26 (14.5) | 28 (15.6) | 47 (26.3) | 39 (21.8) | 63 (35.2) | 39 (21.8) | 43 (24.0) |
| Analgesic administration regimen | |||||||||
|
| 64 | 22 (34.4) | 8 (12.5) | 11 (17.2) | 14 (21.9) | 18 (28.1) | 26 (40.6) | 13 (20.3) | 16 (25.0) |
|
| 95 | 44 (46.3) | 15 (15.8) | 13 (13.7) | 31 (32.6) | 18 (18.9) | 32 (33.7) | 20 (21.1) | 17 (17.9) |
|
| 14 | 5 (35.7) | 2 (14.3) | 2 (14.3) | 1 (7.1) | 2 (14.3) | 4 (28.6) | 5 (35.7) | 7 (50.0) |
| NSAIDs | |||||||||
| Yes | 103 | 47 (45.6) | 14 (13.6) | 14 (13.6) | 32 (31.1) | 18 (17.5) | 38 (36.9) | 24 (23.3) | 19 (18.4) |
| NSAIDs administration regimen | |||||||||
|
| 25 | 9 (36.0) | 2 (8.0) | 5 (20.0) | 9 (36.0) | 5 (20.0) | 10 (40.0) | 6 (24.0) | 4 (16.0) |
|
| 68 | 34 (50.0) | 9 (13.2) | 8 (11.8) | 23 (33.8) | 12 (17.6) | 24 (35.3) | 14 (20.6) | 12 (17.6) |
|
| 8 | 3 (37.5) | 2 (25.0) | 1 (12.5) | 0 (0.0) | 1 (12.5) | 3 (37.5) | 3 (37.5) | 3 (37.5) |
| Opioids | |||||||||
| Yes | 63 | 21 (33.3) | 9 (14.3) | 14 (22.2) | 12 (19.0) | 17 (27.0) | 21 (33.3) | 11 (17.5) | 21 (33.3) |
| Opioids administration regimen | |||||||||
|
| 30 | 10 (33.3) | 4 (13.3) | 6 (20.0) | 2 (6.7) | 10 (33.3) | 14 (46.7) | 4 (13.3) | 10 (33.3) |
|
| 24 | 8 (33.3) | 5 (20.8) | 5 (20.8) | 8 (33.3) | 6 (25.0) | 6 (25.0) | 5 (20.8) | 5 (20.8) |
|
| 5 | 2 (40.0) | 0 (0.0) | 1 (20.0) | 1 (20.0) | 0 (0.0) | 1 (20.0) | 2 (40.0) | 3 (60.0) |
| NSAIDs + opioids | |||||||||
| Yes | 13 | 5 (38.5) | 3 (23.1) | 0 (0.0) | 3 (23.1) | 4 (30.8) | 4 (30.8) | 4 (30.8) | 3 (23.1) |
| NSAIDs + opioids administration regimen | |||||||||
|
| 9 | 3 (33.3) | 2 (22.2) | 0 (0.0) | 3 (33.3) | 3 (33.3) | 2 (22.2) | 3 (33.3) | 2 (22.2) |
|
| 3 | 2 (66.7) | 1 (33.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (66.7) | 1 (33.3) | 0 (0.0) |
|
| 1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) |
Distribution and proportions of NEP and PSRP pain categories in the sample split by congruence-moderator subsets.
NEP: nurse estimation of pain; PSRP: patient self-reported pain; NSAIDs: nonsteroidal anti-inflammatory drugs; ATC: around the clock; and PRN: on demand.
aAssessor's assertion.
Congruence categories dependence upon the PSRP category split by congruence moderators.
| Moderator |
| PSRP category | |
|---|---|---|---|
| No-pain | Severe | ||
| Pain in the past 24 h | |||
| No | 330.004a | Cong. | |
| Yes | 236.296a | Under | |
| Cause of pain | |||
| Surgery | 96.896a | Under | |
| Trauma | 13.606c | Under | |
| Diagnostic procedures | 24.105a | Under | |
| Cancer | 36.897a | Under | |
| Other | 78.644a | Over | |
| Unknown | 17.079b | Under | |
| Analgesics in the past 24 h | |||
| No | 386.394a | Under | |
| Yes | 85.541a | Under | |
| NSAIDs | |||
| Yes | 85.541a | Under | |
| NSAIDs administration modality | |||
|
| 17.222b | Under | |
|
| 35.952a | Under | |
|
| 8.000d | — | |
| Opioids | |||
| Yes | 32.739a | Under | |
| Opioids administration modality | |||
|
| 23.476a | Under | |
|
| 14.267c | Under | |
|
| e | ||
| NSAIDs + opioids | |||
| Yes | 4.658d | ||
| NSAIDs + opioids administration modality | |||
|
| 4.400d | ||
|
| e | ||
|
| e | ||
χ 2 analysis of the congruence categories dependence upon the PSRP category split by moderator subset (mild and moderate pain categories are not reported as there were no associations with these categories); the CCs responsible for a dependence, as found on post hoc analysis, are also reported.
In all analyses Degree of Freedom (DF) was 6 (except for pain in the past 24 h: DF = 4).
a P < 0.001; b P < 0.01; c P < 0.05; dnot significant; and einsufficient data for analysis.
NSAIDs: nonsteroidal anti-inflammatory drugs; ATC: around the clock; PRN: on demand; Cong.: congruence; under: underestimation; and over: overestimation.
Figure 1Radar plots of CCs proportions in each PSRP category within the subsets of patients with and without pain experience (a) and within the subsets of patients with and without analgesic prescription (b).